Lung study points to therapies for chronic coughing disease

June 13, 2018, University of Edinburgh

Fresh insights into a potentially life-threatening lung disease that causes persistent coughing could pave the way for new therapies.

Scientists have discovered how the disease impairs key cells of the immune system, leaving patients prone to repeated caused by bacteria such as pneumonia.

Treatments that boost the antibacterial functions of these key cells could help to reduce the number of chest infections experienced by patients and improve their quality of life, researchers say.

The condition—called —is associated with a vicious cycle of bacterial and inflammation in the airways and lungs.

In healthy people, inflammation helps to clear infections but in patients with bronchiectasis, this process is not effective. This leads to further inflammation, which can instead damage the airways, leaving patients even more vulnerable to infections and causing even more .

The team from the University of Edinburgh focused on cells called neutrophils, which are the body's first line of defence against infections.

Patients with bronchiectasis have an excess of neutrophils in their airways compared with healthy people, so it was not understood why they are prone to repeated infections.

The researchers found that neutrophils from patients with bronchiectasis do not behave in the same way as those from healthy people—the neutrophils live longer, are more activated and have altered functions.

These cells were unable to kill bacteria as effectively as those from . This was worse during a new infection, and may help explain why patients were not able to clear bacteria from their body.

The study involved 18 patients with bronchiectasis, eight healthy volunteers and six pneumonia patients with no background .

The researchers say the findings warrant further investigation of how neutrophil function could be improved in bronchiectasis , and whether this could help stop the cycle of infections.

Around one in 1000 people in the UK are affected by bronchiectasis, which can be life-threatening. Patients experience symptoms including shortness of breath, chronic coughing and excessive phlegm production.

The study, published in the American Journal of Respiratory and Critical Care Medicine, was funded by the Chief Scientist Office of the Scottish Government and the UK Medical Research Council.

Dr. Pallavi Bedi, of the MRC Centre for Inflammation Research at the University of Edinburgh, said: "This study has identified that the key cells in bronchiectasis—the neutrophils—are reprogrammed and do not function as they normally should do. This should now help us to develop more targeted, non-antibiotic therapies in bronchiectasis. "

Explore further: Statins could ease coughing in lung disease patients, study finds

More information: Pallavi Bedi et al, Blood Neutrophils are Reprogrammed in Bronchiectasis., American Journal of Respiratory and Critical Care Medicine (2018). DOI: 10.1164/rccm.201712-2423OC

Related Stories

Statins could ease coughing in lung disease patients, study finds

March 24, 2014
Common cholesterol-lowering drugs could provide relief to patients suffering from a chronic lung disease, a study has shown.

'Dickensian' lung disease rates on the rise in UK pensioners

November 5, 2015
The number of people diagnosed with bronchiectasis, a lung condition thought to be a 'disease of the past', has risen considerably in the past decade and now affects more than 1% of UK pensioners, finds a new study by UCL, ...

A new treatment for antibiotic resistant bacteria and infectious disease

March 31, 2017
A study, published in the American Journal of Respiratory and Critical Care Medicine, describes a new treatment pathway for antibiotic resistant bacteria and infectious diseases with benefits for patients and health care ...

Lung therapy hope for critical illness

May 8, 2017
Scientists have pinpointed a chemical signal that worsens inflammation linked to a life-threatening lung condition.

Research sheds light on a novel disease mechanism in chronic smokers

May 21, 2018
Research published in the journal Clinical Science suggests that an immune signalling protein called interleukin (IL)-26 is increased among chronic smokers with lung disease and this involvement reveals disease mechanisms ...

Breakthrough could give new hope to sufferers of Cystic Fibrosis

August 12, 2014
Cystic Fibrosis is a devastating genetic disease which afflicts over 10,000 children across the country. The disease results in a declining lung function, which in turn leads to a higher likelihood of developing lung infections. ...

Recommended for you

Collaboration yields possible treatment for rare neurodegenerative disorder

October 23, 2018
St. Jude Children's Research Hospital investigators have developed a new class of compounds that extended the lives and eased symptoms of mice with a progressive neurodegenerative human disorder. The findings appear today ...

'Game changer' tuberculosis drug cures 9 in 10

October 22, 2018
A new treatment for a drug-resistant strain of tuberculosis can cure more than 90 percent of sufferers, according to a trial hailed Monday as a "game changer" in the fight against the global killer.

AI doctor could boost chance of survival for sepsis patients

October 22, 2018
Scientists have created an artificial intelligence system that could help treat patients with sepsis.

A guide to Acute flaccid myelitis (AFM), the rare, polio-like illness making young children sick

October 22, 2018
A fast-acting, polio-like illness has sickened 62 young children, with an average age of 4, in 22 U.S. states so far this fall.

Scientists in Sweden may have figured out one way acne bacteria defies treatment

October 22, 2018
Researchers in Sweden have discovered how acne-causing bacteria feed off their human hosts. The study, which was performed at KTH Royal Institute of Technology, could make it possible to find effective ways to treat severe ...

Consuming caffeine from coffee reduces incident rosacea

October 22, 2018
(HealthDay)—Caffeine intake from coffee is inversely associated with the risk for incident rosacea, according to a study published online Oct. 17 in JAMA Dermatology.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.